Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1998 1
2002 4
2003 1
2004 2
2005 6
2006 2
2007 1
2008 2
2009 4
2010 3
2011 1
2012 8
2013 5
2014 2
2016 6
2017 9
2018 4
2019 9
2020 8
2021 8
2022 4
Text availability
Article attribute
Article type
Publication date

Search Results

82 results
Results by year
Filters applied: . Clear all
Page 1
Genome-wide analysis identifies NR4A1 as a key mediator of T cell dysfunction.
Liu X, Wang Y, Lu H, Li J, Yan X, Xiao M, Hao J, Alekseev A, Khong H, Chen T, Huang R, Wu J, Zhao Q, Wu Q, Xu S, Wang X, Jin W, Yu S, Wang Y, Wei L, Wang A, Zhong B, Ni L, Liu X, Nurieva R, Ye L, Tian Q, Bian XW, Dong C. Liu X, et al. Among authors: khong h. Nature. 2019 Mar;567(7749):525-529. doi: 10.1038/s41586-019-0979-8. Epub 2019 Feb 27. Nature. 2019. PMID: 30814730 Free PMC article.
Bempegaldesleukin selectively depletes intratumoral Tregs and potentiates T cell-mediated cancer therapy.
Sharma M, Khong H, Fa'ak F, Bentebibel SE, Janssen LME, Chesson BC, Creasy CA, Forget MA, Kahn LMS, Pazdrak B, Karki B, Hailemichael Y, Singh M, Vianden C, Vennam S, Bharadwaj U, Tweardy DJ, Haymaker C, Bernatchez C, Huang S, Rajapakshe K, Coarfa C, Hurwitz ME, Sznol M, Hwu P, Hoch U, Addepalli M, Charych DH, Zalevsky J, Diab A, Overwijk WW. Sharma M, et al. Among authors: khong h. Nat Commun. 2020 Jan 31;11(1):661. doi: 10.1038/s41467-020-14471-1. Nat Commun. 2020. PMID: 32005826 Free PMC article. Clinical Trial.
Adjuvants for peptide-based cancer vaccines.
Khong H, Overwijk WW. Khong H, et al. J Immunother Cancer. 2016 Sep 20;4:56. doi: 10.1186/s40425-016-0160-y. eCollection 2016. J Immunother Cancer. 2016. PMID: 27660710 Free PMC article. Review.
Elacestrant (oral selective estrogen receptor degrader) Versus Standard Endocrine Therapy for Estrogen Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Advanced Breast Cancer: Results From the Randomized Phase III EMERALD Trial.
Bidard FC, Kaklamani VG, Neven P, Streich G, Montero AJ, Forget F, Mouret-Reynier MA, Sohn JH, Taylor D, Harnden KK, Khong H, Kocsis J, Dalenc F, Dillon PM, Babu S, Waters S, Deleu I, García Sáenz JA, Bria E, Cazzaniga M, Lu J, Aftimos P, Cortés J, Liu S, Tonini G, Laurent D, Habboubi N, Conlan MG, Bardia A. Bidard FC, et al. Among authors: khong h. J Clin Oncol. 2022 May 18:JCO2200338. doi: 10.1200/JCO.22.00338. Online ahead of print. J Clin Oncol. 2022. PMID: 35584336
Demethylating Agents in the Treatment of Cancer.
Howell PM, Liu Z, Khong HT. Howell PM, et al. Among authors: khong ht. Pharmaceuticals (Basel). 2010 Jul 2;3(7):2022-2044. doi: 10.3390/ph3072022. Pharmaceuticals (Basel). 2010. PMID: 27713340 Free PMC article. Review.
Coronavirus Disease Contact Tracing Outcomes and Cost, Salt Lake County, Utah, USA, March-May 2020.
Fields VL, Kracalik IT, Carthel C, Lopez A, Schwartz A, Lewis NM, Bray M, Claflin C, Jorgensen K, Khong H, Richards W, Risk I, Smithee M, Clawson M, Booth LC, Scribellito T, Lowry J, Huynh J, Davis L, Birch H, Tran T, Walker J, Fry A, Hall A, Baker J, Pevzner E, Dunn AC, Tate JE, Kirking HL, Kiphibane T, Tran CH. Fields VL, et al. Among authors: khong h. Emerg Infect Dis. 2021 Dec;27(12):2999-3008. doi: 10.3201/eid2712.210505. Epub 2021 Oct 26. Emerg Infect Dis. 2021. PMID: 34698628 Free PMC article.
Preclinical Immune Response and Safety Evaluation of the Protein Subunit Vaccine Nanocovax for COVID-19.
Tran TNM, May BP, Ung TT, Nguyen MK, Nguyen TTT, Dinh VL, Doan CC, Tran TV, Khong H, Nguyen TTT, Hua HQH, Nguyen VA, Ha TP, Phan DL, Nguyen TA, Bui TN, Tu TM, Nguyen TT, Le TTH, Dong TL, Huynh TH, Ho PH, Le NTT, Truong CT, Pham HP, Luong CY, Y NL, Cao MN, Nguyen DK, Le TT, Vuong DC, Nguyen LKH, Do MS. Tran TNM, et al. Among authors: khong h. Front Immunol. 2021 Dec 6;12:766112. doi: 10.3389/fimmu.2021.766112. eCollection 2021. Front Immunol. 2021. PMID: 34938290 Free PMC article.
Real-world benefit of combination palbociclib and endocrine therapy for metastatic breast cancer and correlation with neutropenia.
Sun J, Zhong X, Ma J, Sun W, Han HS, Soliman HH, Loftus LS, Costa RLB, Armaghani AJ, Soyano-Muller AE, Czerniecki BJ, Lee MC, Kiluk JV, Khakpour N, Hoover SJ, Laronga C, Khong HT. Sun J, et al. Among authors: khong ht. Cancer Med. 2021 Nov;10(21):7665-7672. doi: 10.1002/cam4.4295. Epub 2021 Sep 30. Cancer Med. 2021. PMID: 34590788 Free PMC article.
82 results